ASPI Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
5.1M
+22.6%
4.2M
-74.9%
16.7M
+240.7%
4.9M
+308.1%
1.2M
Cost of Revenue
3.6M
+44.9%
2.5M
-82.8%
14.6M
+226.4%
4.5M
+613.5%
626.0K
Gross Profit
1.5M
-11.2%
1.7M
-20.0%
2.1M
+392.2%
423.2K
-26.0%
572.0K
Operating Expenses
35.7M
+34.3%
26.6M
-2.0%
27.1M
+76.1%
15.4M
+22.7%
12.5M
R&D
6.8M
+29.7%
5.3M
-45.0%
9.6M
+208.8%
3.1M
+252.1%
880.0K
SG&A
28.9M
+35.5%
21.3M
+21.4%
17.5M
+42.7%
12.3M
+5.4%
11.7M
Operating Income
-34195000
-37.4%
-24888000
+0.5%
-25020139
-67.2%
-14966939
-25.0%
-11969000
EBITDA
-32993000
-51.1%
-21831000
+9.4%
-24083414
-64.2%
-14670623
-28.3%
-11439000
Net Income
-33993000
-27.3%
-26706000
+57.8%
-63330807
-391.2%
-12893602
+82.8%
-75157000
EPS (Basic)
$-0.27
-350.0%
$-0.06
+92.3%
$-0.78
-420.0%
$-0.15
+85.4%
$-1.03
EPS (Diluted)
$-0.27
-350.0%
$-0.06
+92.3%
$-0.78
-420.0%
$-0.15
+85.4%
$-1.03
Shares (Diluted)
122.7M
+1.4%
121.0M
+19.8%
101.0M
+14.1%
88.6M
+21.3%
73.0M
ASP Isotopes (ASPI) โ€” Financials